# Object Record 0
**objectId:** dashboard-item-1759853783245-patient-context
**type:** component
**componentType:** PatientContext
**description:** 
**content title:** Patient Context
**content component:** PatientContext
**content props patientData patient name:** Sarah Miller
**content props patientData patient date of birth:** 1962-03-15
**content props patientData patient age:** 63
**content props patientData patient sex:** Female
**content props patientData patient age at first encounter:** 53
**content props patientData patient identifiers mrn:** MC-001001
**content props patientData riskLevel:** high
**content props patientData primaryDiagnosis:** Rheumatoid arthritis
**content props patientData problem list 0 name:** Rheumatoid arthritis
**content props patientData problem list 0 status:** active
**content props patientData problem list 1 name:** Essential hypertension
**content props patientData problem list 1 status:** active
**content props patientData problem list 2 name:** Mild chronic kidney disease
**content props patientData problem list 2 status:** active
**content props patientData medication timeline 0 name:** Methotrexate
**content props patientData medication timeline 0 dose:** 20 mg
**content props patientData medication timeline 0 route:** PO
**content props patientData medication timeline 0 frequency:** weekly
**content props patientData medication timeline 0 start:** 2018-09-05
**content props patientData medication timeline 1 name:** Folic Acid
**content props patientData medication timeline 1 dose:** 5 mg
**content props patientData medication timeline 1 route:** PO
**content props patientData medication timeline 1 frequency:** weekly
**content props patientData medication timeline 1 start:** 2015-08-10
**content props patientData medication timeline 2 name:** Lisinopril
**content props patientData medication timeline 2 dose:** 10 mg
**content props patientData medication timeline 2 route:** PO
**content props patientData medication timeline 2 frequency:** daily
**content props patientData medication timeline 2 start:** 2018-09-05
**content props patientData medication timeline 3 name:** Trimethoprim-Sulfamethoxazole
**content props patientData medication timeline 3 dose:** 800/160 mg
**content props patientData medication timeline 3 route:** PO
**content props patientData medication timeline 3 frequency:** BID
**content props patientData medication timeline 3 start:** 2025-06-15
**content props patientData medication timeline 3 end:** 2025-06-25
**content props patientData allergies 0:** Penicillin (rash)
**createdAt:** 2025-10-14T16:16:23.245Z
**updatedAt:** 2025-10-14T16:16:23.245Z

# Object Record 1
**objectId:** dashboard-item-1759906076097-medication-timeline
**type:** component
**componentType:** MedicationTimeline
**description:** 
**content title:** Medication Timeline
**content component:** MedicationTimeline
**content props encounters 0 encounter no:** 1
**content props encounters 0 date:** 2015-08-10
**content props encounters 0 type:** Rheumatology Initial Consult
**content props encounters 0 provider:** Dr. Elizabeth Hayes
**content props encounters 0 diagnosis:** Seropositive Rheumatoid Arthritis (active)
**content props encounters 0 medications 0:** Methotrexate 10mg weekly
**content props encounters 0 medications 1:** Folic Acid 5mg weekly
**content props encounters 0 notes:** Started MTX therapy with folic acid supplementation
**content props encounters 1 encounter no:** 2
**content props encounters 1 date:** 2016-02-20
**content props encounters 1 type:** General Practice
**content props encounters 1 provider:** GP
**content props encounters 1 diagnosis:** Stable RA on MTX
**content props encounters 1 medications 0:** Methotrexate 10mg weekly
**content props encounters 1 medications 1:** Folic Acid 5mg weekly
**content props encounters 1 notes:** Good RA control on MTX 10 mg weekly; no MTX side effects
**content props encounters 2 encounter no:** 3
**content props encounters 2 date:** 2018-09-05
**content props encounters 2 type:** General Practice
**content props encounters 2 provider:** GP
**content props encounters 2 diagnosis:** New essential hypertension; RA stable; plan MTX dose increase
**content props encounters 2 medications 0:** Methotrexate 20mg weekly
**content props encounters 2 medications 1:** Folic Acid 5mg weekly
**content props encounters 2 medications 2:** Lisinopril 10mg daily
**content props encounters 2 notes:** Elevated BP readings 145–155/90–95; MTX increased to 20mg
**content props encounters 3 encounter no:** 4
**content props encounters 3 date:** 2021-03-15
**content props encounters 3 type:** General Practice
**content props encounters 3 provider:** GP
**content props encounters 3 diagnosis:** Stable RA; controlled HTN; mild CKD (stable)
**content props encounters 3 medications 0:** Methotrexate 20mg weekly
**content props encounters 3 medications 1:** Folic Acid 5mg weekly
**content props encounters 3 medications 2:** Lisinopril 10mg daily
**content props encounters 3 notes:** Overall well; RA controlled on MTX 20 mg; BP controlled
**content props encounters 4 encounter no:** 5
**content props encounters 4 date:** 2025-06-15
**content props encounters 4 type:** General Practice
**content props encounters 4 provider:** GP
**content props encounters 4 diagnosis:** Acute bacterial sinusitis; RA/HTN/CKD stable
**content props encounters 4 medications 0:** Trimethoprim-Sulfamethoxazole 800/160mg BID
**content props encounters 4 notes:** 5 days nasal congestion, facial pain, headache, green discharge
**content props encounters 5 encounter no:** 6
**content props encounters 5 date:** 2025-06-21
**content props encounters 5 type:** Emergency Medicine
**content props encounters 5 provider:** Dr. Sarah Chen
**content props encounters 5 diagnosis:** Acute liver injury likely DILI and/or severe methotrexate toxicity
**content props encounters 5 notes:** Severe fatigue, jaundice, epigastric pain, confusion
**content props medicationTimeline 0 name:** Methotrexate
**content props medicationTimeline 0 startDate:** 2015-08-10
**content props medicationTimeline 0 endDate:** 2018-09-05
**content props medicationTimeline 0 dose:** 10mg weekly
**content props medicationTimeline 0 indication:** RA
**content props medicationTimeline 1 name:** Methotrexate
**content props medicationTimeline 1 startDate:** 2018-09-05
**content props medicationTimeline 1 dose:** 20mg weekly
**content props medicationTimeline 1 indication:** RA
**content props medicationTimeline 2 name:** Folic Acid
**content props medicationTimeline 2 startDate:** 2015-08-10
**content props medicationTimeline 2 dose:** 5mg weekly
**content props medicationTimeline 2 indication:** MTX supplementation
**content props medicationTimeline 3 name:** Lisinopril
**content props medicationTimeline 3 startDate:** 2018-09-05
**content props medicationTimeline 3 dose:** 10mg daily
**content props medicationTimeline 3 indication:** Hypertension
**content props medicationTimeline 4 name:** Trimethoprim-Sulfamethoxazole
**content props medicationTimeline 4 startDate:** 2025-06-15
**content props medicationTimeline 4 endDate:** 2025-06-25
**content props medicationTimeline 4 dose:** 800/160mg BID
**content props medicationTimeline 4 indication:** Acute bacterial sinusitis
**createdAt:** 2025-10-14T16:47:56.098Z
**updatedAt:** 2025-10-14T16:47:56.098Z

# Object Record 4
**objectId:** dashboard-item-1759906246156-lab-chart
**type:** component
**componentType:** LabChart
**description:** 
**content title:** Lab Trends
**content component:** LabChart
**content props encounters 0 encounter no:** 1
**content props encounters 0 date:** 2015-08-10
**content props encounters 0 meta ui risk color:** green
**content props encounters 1 encounter no:** 2
**content props encounters 1 date:** 2016-02-20
**content props encounters 1 meta ui risk color:** green
**content props encounters 2 encounter no:** 3
**content props encounters 2 date:** 2018-09-05
**content props encounters 2 meta ui risk color:** green
**content props encounters 3 encounter no:** 4
**content props encounters 3 date:** 2021-03-15
**content props encounters 3 meta ui risk color:** green
**content props encounters 4 encounter no:** 5
**content props encounters 4 date:** 2025-06-15
**content props encounters 4 meta ui risk color:** amber
**content props encounters 5 encounter no:** 6
**content props encounters 5 date:** 2025-06-21
**content props encounters 5 meta ui risk color:** red
**content props encounters 5 meta event tags 0:** Suspected DILI
**content props encounters 5 meta event tags 1:** Potential MTX toxicity
**content props medicationTimeline 0 name:** Methotrexate
**content props medicationTimeline 0 start:** 2015-08-10
**content props medicationTimeline 0 dose:** 10mg weekly
**content props medicationTimeline 1 name:** Methotrexate
**content props medicationTimeline 1 start:** 2018-09-05
**content props medicationTimeline 1 dose:** 20mg weekly
**content props medicationTimeline 2 name:** Lisinopril
**content props medicationTimeline 2 start:** 2018-09-05
**content props medicationTimeline 2 dose:** 10mg daily
**content props medicationTimeline 3 name:** Trimethoprim-Sulfamethoxazole
**content props medicationTimeline 3 start:** 2025-06-15
**content props medicationTimeline 3 end:** 2025-06-25
**content props medicationTimeline 3 dose:** 800/160mg BID
**createdAt:** 2025-10-14T16:50:46.156Z
**updatedAt:** 2025-10-14T16:50:46.156Z

# Object Record 3
**objectId:** dashboard-item-1759906300004-single-encounter-4
**type:** component
**componentType:** SingleEncounterDocument
**description:** 
**content title:** Encounter #4 - Outpatient (Chronic Review)
**content component:** SingleEncounterDocument
**content props encounter encounter no:** 4
**content props encounter meta visit type:** Outpatient
**content props encounter meta date time:** 2021-03-15T09:00:00
**content props encounter meta provider name:** None
**content props encounter meta provider specialty:** General Practice
**content props encounter meta ui risk color:** green
**content props encounter reason for visit:** Routine chronic disease review (RA, HTN)
**content props encounter chief complaint:** Routine follow-up for RA/HTN
**content props encounter hpi:** Overall well; RA controlled on MTX 20 mg; BP controlled on Lisinopril; occasional low back pain; eGFR mildly declined but stable; continues 1–2 beers/day.
**content props encounter medications prior 0 name:** Methotrexate
**content props encounter medications prior 0 dose:** 20 mg
**content props encounter medications prior 0 route:** PO
**content props encounter medications prior 0 frequency:** weekly
**content props encounter medications prior 1 name:** Folic Acid
**content props encounter medications prior 1 dose:** 5 mg
**content props encounter medications prior 1 route:** PO
**content props encounter medications prior 1 frequency:** weekly (next day after MTX)
**content props encounter medications prior 2 name:** Lisinopril
**content props encounter medications prior 2 dose:** 10 mg
**content props encounter medications prior 2 route:** PO
**content props encounter medications prior 2 frequency:** daily
**content props encounter medications prior 3 name:** Paracetamol
**content props encounter medications prior 3 dose:** None
**content props encounter medications prior 3 route:** PO
**content props encounter medications prior 3 frequency:** PRN
**content props encounter physical exam general:** Fit/well
**content props encounter physical exam vitals:** BP 130/82, HR 68, RR 16, Temp 36.7°C
**content props encounter physical exam msk:** No synovitis
**content props encounter physical exam abdomen:** Soft, non-tender
**content props encounter assessment impression:** Stable RA; controlled HTN; chronic mild low back pain; mild CKD (stable)
**content props encounter plan investigations labs 0:** CBC
**content props encounter plan investigations labs 1:** LFTs
**content props encounter plan investigations labs 2:** Creatinine
**content props encounter plan investigations labs 3:** eGFR
**content props encounter plan management education 0:** Continue MTX 20 mg weekly, Folic Acid 5 mg weekly, Lisinopril 10 mg daily
**content props encounter plan management education 1:** Hydration importance with CKD and ACE inhibitor
**content props encounter plan management education 2:** Alcohol moderation reinforced
**content props patient name:** Sarah Miller
**content props patient sex:** Female
**content props patient age at first encounter:** 53
**content props encounterIndex:** 3
**content props dataSource:** ICE
**createdAt:** 2025-10-15T08:00:00.000Z
**updatedAt:** 2025-10-15T08:00:00.000Z

# Object Record 1
**objectId:** dashboard-item-1759906300004-single-encounter-2
**type:** component
**componentType:** SingleEncounterDocument
**description:** 
**content title:** Encounter #2 - Outpatient Review
**content component:** SingleEncounterDocument
**content props encounter encounter no:** 2
**content props encounter meta visit type:** Outpatient
**content props encounter meta date time:** 2016-02-20T09:30:00
**content props encounter meta provider name:** None
**content props encounter meta provider specialty:** General Practice
**content props encounter meta ui risk color:** green
**content props encounter reason for visit:** Routine MTX monitoring and RA review
**content props encounter chief complaint:** Routine medication monitoring; RA follow-up
**content props encounter hpi:** Good RA control on MTX 10 mg weekly; no MTX side effects; occasional joint aches; adherent to MTX and folic acid; no new concerns.
**content props encounter medications prior 0 name:** Methotrexate
**content props encounter medications prior 0 dose:** 10 mg
**content props encounter medications prior 0 route:** PO
**content props encounter medications prior 0 frequency:** weekly
**content props encounter medications prior 1 name:** Folic Acid
**content props encounter medications prior 1 dose:** 5 mg
**content props encounter medications prior 1 route:** PO
**content props encounter medications prior 1 frequency:** weekly
**content props encounter medications prior 2 name:** Paracetamol
**content props encounter medications prior 2 dose:** None
**content props encounter medications prior 2 route:** PO
**content props encounter medications prior 2 frequency:** PRN
**content props encounter physical exam general:** Well; no jaundice
**content props encounter physical exam msk:** No active synovitis; mild residual hand deformities
**content props encounter physical exam vitals:** BP 132/80, HR 70, RR 16, Temp 36.7°C
**content props encounter assessment impression:** Stable RA on MTX
**content props encounter plan investigations labs 0:** CBC
**content props encounter plan investigations labs 1:** LFTs
**content props encounter plan investigations labs 2:** Renal function (Creatinine, eGFR)
**content props encounter plan management education 0:** Continue Methotrexate 10 mg weekly and Folic Acid 5 mg weekly
**content props encounter plan management education 1:** Strict alcohol avoidance while on MTX
**content props encounter plan management education 2:** Smoking cessation encouraged; referral offered
**content props patient name:** Sarah Miller
**content props patient sex:** Female
**content props patient age at first encounter:** 53
**content props encounterIndex:** 1
**content props dataSource:** Medilogik
**createdAt:** 2025-10-15T08:00:00.000Z
**updatedAt:** 2025-10-15T08:00:00.000Z

# Object Record 2
**objectId:** dashboard-item-1759906300004-single-encounter-3
**type:** component
**componentType:** SingleEncounterDocument
**description:** 
**content title:** Encounter #3 - Outpatient (Elevated BP)
**content component:** SingleEncounterDocument
**content props encounter encounter no:** 3
**content props encounter meta visit type:** Outpatient
**content props encounter meta date time:** 2018-09-05T10:00:00
**content props encounter meta provider name:** None
**content props encounter meta provider specialty:** General Practice
**content props encounter meta ui risk color:** green
**content props encounter reason for visit:** Routine review; elevated blood pressure
**content props encounter chief complaint:** Raised BP readings at home
**content props encounter hpi:** BP 145–155/90–95; asymptomatic. RA well-controlled on MTX 10 mg but specialist advised increase to 20 mg for mild flares. Quit smoking in 2017; continues 1–2 beers/day.
**content props encounter medications prior 0 name:** Methotrexate
**content props encounter medications prior 0 dose:** 10 mg
**content props encounter medications prior 0 route:** PO
**content props encounter medications prior 0 frequency:** weekly
**content props encounter medications prior 1 name:** Folic Acid
**content props encounter medications prior 1 dose:** 5 mg
**content props encounter medications prior 1 route:** PO
**content props encounter medications prior 1 frequency:** weekly
**content props encounter medications prior 2 name:** Paracetamol
**content props encounter medications prior 2 dose:** None
**content props encounter medications prior 2 route:** PO
**content props encounter medications prior 2 frequency:** PRN
**content props encounter physical exam general:** Well
**content props encounter physical exam vitals:** BP 148/92, HR 72, RR 16, Temp 36.8°C
**content props encounter physical exam cvs:** Normal S1/S2, no murmurs
**content props encounter physical exam msk:** No active synovitis
**content props encounter assessment impression:** New essential hypertension; RA stable; plan MTX dose increase
**content props encounter plan investigations labs 0:** CBC
**content props encounter plan investigations labs 1:** LFTs
**content props encounter plan investigations labs 2:** Creatinine
**content props encounter plan investigations labs 3:** eGFR
**content props encounter plan management medications started 0 name:** Lisinopril
**content props encounter plan management medications started 0 dose:** 10 mg
**content props encounter plan management medications started 0 route:** PO
**content props encounter plan management medications started 0 frequency:** daily
**content props encounter plan management medications started 1 name:** Methotrexate
**content props encounter plan management medications started 1 dose:** 20 mg
**content props encounter plan management medications started 1 route:** PO
**content props encounter plan management medications started 1 frequency:** weekly
**content props encounter plan management education 0:** Lisinopril side effects (e.g., cough); monitor BP regularly
**content props encounter plan management education 1:** Reinforce alcohol moderation with higher MTX dose
**content props encounter plan management education 2:** Continue Folic Acid the day after MTX
**content props patient name:** Sarah Miller
**content props patient sex:** Female
**content props patient age at first encounter:** 53
**content props encounterIndex:** 2
**content props dataSource:** Viper
**createdAt:** 2025-10-15T08:00:00.000Z
**updatedAt:** 2025-10-15T08:00:00.000Z